BiotechTube
Home/Radiomer Therapeutics/Mark Worscheh, MBA
MW

Mark Worscheh, MBA

Chief Financial Officer

Radiomer Therapeutics

Roles

Chief Financial OfficeratRadiomer Therapeutics
Chief Financial OfficeratAllterum Therapeutics

Therapeutic Areas

Oncology

Radiomer Therapeutics Pipeline

DrugIndicationPhase
Lead Program (undisclosed)OncologyPre-clinical

Leadership Team at Radiomer Therapeutics

AV
Atul Varadhachary, MD, PhD
Chief Executive Officer
PB
Philip Breitfeld, MD
Chief Medical Officer
MJ
Michael J. Heffernan, PhD, PE
Vice President of Operations
SD
Sougata Dey, PhD
Director of Chemistry
View full Radiomer Therapeutics profile